Moneta Group Investment Advisors LLC Merck & Co., Inc. Transaction History

Moneta Group Investment Advisors LLC

$5.03 Billion
Q4 2023

A detailed history of Moneta Group Investment Advisors LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Moneta Group Investment Advisors LLC holds 54,848 shares of MRK stock, worth $6.94 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

54,848

Previous 54,839 0.02%

Holding current value

$6.94 Million

Previous $5.65 Million 5.92%

% of portfolio

0.12%

Previous 0.13%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 15, 2024	BUY	$100.18 - $109.02 $901 - $981	9 Added 0.02%	54,848 $5.98 Million
Q3 2023 Nov 15, 2023	BUY	$102.95 - $114.33 $45,195 - $50,190	439 Added 0.81%	54,839 $5.65 Million
Q2 2023 Aug 15, 2023	BUY	$108.61 - $118.38 $250,454 - $272,984	2,306 Added 4.43%	54,400 $6.28 Million
Q1 2023 May 15, 2023	BUY	$102.94 - $114.86 $1.21 Million - $1.35 Million	11,717 Added 29.02%	52,094 $5.54 Million
Q4 2022 Feb 16, 2023	BUY	$87.44 - $112.11 $91,812 - $117,715	1,050 Added 2.67%	40,377 $4.48 Million

Q4 2022 Feb 16, 2023	SELL	$87.44 - $112.11 $3.44 Billion - $4.4 Billion	-39,288,163 Reduced 99.9%	39,327 $4.36 Million
Q4 2022 Feb 15, 2023	BUY	$87.44 - $112.11 $3.44 Billion - $4.4 Billion	39,289,404 Added 103159.7%	39,327,490 $4.36 Billion
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $11,411 - $12,819	135 Added 0.36%	38,086 $3.28 Million
Q2 2022 Aug 15, 2022	SELL	$83.49 - $94.64 $129,326 - $146,597	-1,549 Reduced 3.92%	37,951 $3.46 Million
Q1 2022 May 11, 2022	BUY	$73.51 - $82.4 $42,488 - $47,627	578 Added 1.49%	39,500 $3.24 Million
Q4 2021 Feb 11, 2022	BUY	$72.28 - $90.54 $187,132 - $234,408	2,589 Added 7.13%	38,922 $2.98 Million
Q3 2021 Nov 12, 2021	SELL	$71.68 - $78.83 $204,072 - $224,429	-2,847 Reduced 7.27%	36,333 $2.73 Million
Q2 2021 Aug 13, 2021	BUY	$70.31 - $77.77 $269,427 - $298,014	3,832 Added 10.84%	39,180 $3.05 Million
Q1 2021 May 14, 2021	BUY	$68.86 - $81.11 $1.46 Million - $1.72 Million	21,204 Added 149.92%	35,348 $2.73 Million
Q4 2020 Feb 12, 2021	SELL	$71.77 - $79.65 $97,535 - $108,244	-1,359 Reduced 8.77%	14,144 $1.16 Million
Q3 2020 Nov 13, 2020	BUY	$73.18 - $82.95 $263,887 - $299,117	3,606 Added 30.31%	15,503 $1.29 Million
Q2 2020 Aug 12, 2020	BUY	$70.42 - $80.13 $90,912 - $103,447	1,291 Added 12.17%	11,897 $920,000
Q1 2020 May 13, 2020	BUY	$63.36 - $87.82 $12,291 - $17,037	194 Added 1.86%	10,606 $816,000
Q4 2019 Feb 11, 2020	SELL	$77.58 - $87.54 $12,490 - $14,093	-161 Reduced 1.52%	10,412 $947,000
Q3 2019 Nov 12, 2019	SELL	$76.08 - $82.93 $11,335 - $12,356	-149 Reduced 1.39%	10,573 $890,000
Q2 2019 Aug 16, 2019	BUY	$69.84 - $81.59 $399,345 - $466,531	5,718 Added 114.27%	10,722 $899,000
Q2 2019 Aug 13, 2019	SELL	$69.84 - $81.59 $478,473 - $558,973	-6,851 Reduced 57.79%	5,004 $899,000
Q1 2019 May 15, 2019	SELL	$69.58 - $79.36 $454,566 - $518,458	-6,533 Reduced 35.53%	11,855 $986,000
Q4 2018 Feb 11, 2019	BUY	$65.24 - $75.71 $231,928 - $269,149	3,555 Added 23.97%	18,388 $1.41 Million
Q3 2018 Nov 13, 2018	SELL	$57.69 - $67.84 $414,156 - $487,023	-7,179 Reduced 32.61%	14,833 $1.05 Million
Q2 2018 Aug 15, 2018	SELL	$50.83 - $59.72 $4.09 Million - $4.81 Million	-80,459 Reduced 78.52%	22,012 $1.34 Million
Q2 2018 Aug 15, 2018	BUY	$50.83 - $59.72 $130,073 - $152,823	2,559 Added 2.56%	102,471 $1.34 Million
Q2 2018 Aug 14, 2018	BUY	$50.83 - $59.72 $4.54 Million - $5.33 Million	89,312 Added 842.57%	99,912 $1.5 Million
Q1 2018 May 14, 2018	BUY	$50.96 - $59.23 $210,566 - $244,738	4,132 Added 63.88%	10,600 $409,000
Q4 2017 Feb 13, 2018	SELL	$51.62 - $61.64 $309 - $369	-6 Reduced 0.09%	6,468 $364,000
Q3 2017 Nov 13, 2017	BUY	$58.67 - $63.13 $379,829 - $408,703	6,474	6,474 $415,000

Others Institutions Holding MRK

# of Institutions

3,769

Shares Held

1.87B

Call Options Held

17.3M

Put Options Held

14.8M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $320B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moneta Group Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moneta Group Investment Advisors LLC with notifications on news.

Account

Moneta Group Investment Advisors LLC Merck & Co., Inc. Transaction History